WCN24-756 POVETACICEPT, AN ENHANCED DUAL BAFF/APRIL ANTAGONIST, IN AUTOANTIBODY-ASSOCIATED GLOMERULONEPHRITIS
Saved in:
| Main Authors: | James Tumlin, Sreedhar Mandayam, Arvind Madan, Frank Cortazar, Sang-Woong Han, Hemant Kulkarni, Jonathan Barratt, Brad Rovin, Hong Zhang, Rupert Davies, Amanda Enstrom, Heather Thomas, Jiahua Li, Stanford L. Peng, Harmeet Singh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-04-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924003802 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Obinutuzumab for Relapsing Myeloperoxidase-Antineutrophil Cytoplasmic Autoantibody–Associated Glomerulonephritis
by: Michael Cammarata, et al.
Published: (2025-06-01) -
Explainability of a Deep Learning-Based Classification Model for Antineutrophil Cytoplasmic Autoantibody–Associated Glomerulonephritis
by: Maria A.C. Wester Trejo, et al.
Published: (2025-02-01) -
CLINICAL VALUE OF BAFF AND APRIL CONCENTRATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS
by: T. A. Panafidina, et al.
Published: (2016-07-01) -
Autoantibodies Against Factor B and Factor H Without Pathogenic Effects in a Patient with Immune Complex-Mediated Membranoproliferative Glomerulonephritis
by: Alexandra T. Matola, et al.
Published: (2025-03-01) -
CLINICAL SIGNIFICANCE OF BAFF/BLyS AND APRIL IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS
by: E. V. Suponitskya, et al.
Published: (2014-10-01)